🟢 Lantern Pharma is trading 6.42% up in pre-market with no clear catalyst identified

Lantern Pharma is trading 6.42% up at $1.99 after closing at $1.87 on September 3, 2026, with no clear catalyst identified.

• No new company-specific announcement or clear catalyst was identified for September 4, 2026.
• Recent coverage remains focused on August 14, 2026, second-quarter results and upcoming Open Medicine AI updates, rather than an overnight event.
• Broader pre-market markets are only modestly mixed, so the reason for the move remains unclear.